Please assess the completion status of the following clinical trial:

Trial Title: The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria- Primary study~1. a Veteran or non-Veteran identified as being at risk for suicide and presently under the care of a mental healthcare provider (A release of information from his/her mental healthcare provider is required.)~2. age 18 - 90~3. within the participant's medical history, either~   1. a suicide attempt in the last 6 months, or~  2. a suicide attempt during the adult lifetime AND current diagnosis of an episode of depression as diagnosed on the Mini International Neuropsychiatric Interview (MINI), or~  3. an inpatient admission with suicide risk in the last 6 months, or~  4. an inpatient admission with suicide risk during the adult lifetime AND current diagnosis of an episode of depression as diagnosed on the Mini International Neuropsychiatric Interview (MINI), or~  5. positive suicidal behavior or ideation based on a psychiatrist- administered Columbia-Suicide Severity Rating Scale (C-SSRS) and psychiatrist review of participant medical history and physical\], or~  6. a score of 0 or greater on the Implicit Associations Test-Suicide (IAT-S), or~  7. \> or = 9 on the Beck Hopelessness Scale (BHS) and psychiatrist review of participant medical history and physical~4. participant can safely eat walnuts, pecans, almonds, peanuts and all other nuts~5. participant can safely eat apples, peaches, pears, pomegranates, aronia, jackfruit, and passion fruit~6. participant can safely eat the herb rosemary, and the fish salmon, trout and cod~7. participant can safely drink and eat food that contain whey and/or milk protein~8. willingness to drink the juice boxes 3 times each day for 6 months~9. have a stable residence with adequate space to store the juice~10. capacity to provide written informed consent~Additional inclusion criteria for Depressive Symptoms sub-analysis~1. enrollment in the primary study of suicide risk reduction~2. a Beck Depression Inventory ≥30~3. a diagnosis of a depressive disorder~Additional inclusion criteria for Alcohol and Nicotine use sub-analysis~1. enrollment in the primary study of suicide risk reduction~2. diagnosis of an alcohol use disorder or at risk drinking patterns~3. self-report of smoking \>10 cigarettes/d.~Exclusion criteria-~1. unstable medical conditions requiring immediate attention or medical conditions that preclude potential study participation for the duration of the study~2. history of seizures, except for:~   * febrile seizures during childhood~  * history of a single seizure episode as an adult if not being maintained on anti-seizure medication; this single seizure must not be related to a primary seizure disorder (must not be epilepsy)~3. persons who have received a diagnosis of diabetes~4. those taking Isotretinoin (Accutane)~5. allergy, hypersensitivity, or intolerance to fish oils or omega-3 fats~6. allergy, hypersensitivity, or intolerance to Macadamia nuts or any nuts such as almonds, walnuts, pecans, peanuts, etc.~7. allergy, hypersensitivity, or intolerance to apples, peaches, pears, pomegranates, aronia, jackfruit, and passion fruit~8. allergy, hypersensitivity, or intolerance to the herb rosemary, and the fish: salmon, trout and cod~9. allergy, hypersensitivity, or intolerance to whey and/or milk protein~10. life threatening medical conditions or life expectancy of less than 6 months~11. pregnancy or lactation or intention to become pregnant within the next 12 months~12. acute intoxication or withdrawal from alcohol or other substances (to be determined by a clinical team member)~13. a cognitive impairment severe enough to preclude informed consent or valid responses on self-report questionnaires~14. Body Mass Index (BMI) \<18 or \>45~15. evidence of disordered eating or risk of malnutrition based on the Eating Attitudes Test (EAT-26)~16. relapsing of remitting Multiple Sclerosis~17. unstable or rapidly progressive neurological disease~18. history of significant behavioral instability~19. participating in another research study~20. regular use of anticoagulants such as high dose aspirin, warfarin or Coumadin~21. take hypoglycemic agents~Additional exclusion criteria for fMRI Study only (40 individuals)~* inability or unwillingness to participate in an fMRI scan~* presence of metallic objects in the body that would interfere with the scan~* pronounced claustrophobia~* body weight \>300 pounds

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Study Juice (Type: EXPERIMENTAL): 3,300 mg of Omega-3 HUFAs per day for 6 months~Other names: none
- Placebo Juice (Type: PLACEBO_COMPARATOR): 3,300 mg of macadamia nut oil per day for 6 months~Other names: none

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues